Wyeth Improperly Delayed Generic Effexor: Suit
Wyeth Inc. was hit with a proposed antitrust class action Friday in Mississippi for allegedly using fraudulently obtained patents and sham litigation to delay generic versions of blockbuster antidepressant Effexor XR....To view the full article, register now.
Already a subscriber? Click here to view full article